Lymphoma News

A family funday inspired by a six-year-old boy from Watford who has been battling non-Hodgkin's lymphoma has raised A 5,000 for a children's cancer charity.

Employees at Cancer Genetics, Inc., are on the cutting edge of developing cancer tests, and many employees have personal stories of their own cancers and those of family members who have battled the cancers the company addresses.

Zydelig is indicated in combination with rituximab for patients with relapsed chronic lymphocytic leukemia for whom rituximab alone would be considered appropriate therapy and as monotherapy for patients with relapsed follicular B-cell non-Hodgkin lymphoma and small lymphocytic lymphoma who have received at least two prior systemic therapies.

When I got most of my hair cut off recently, friends, co-workers and neighbours commented and complimented, but no one asked why.

Seventeen-year-old Terry 'Tre' Grinner, who was diagnosed with Hodgkin's Lymphoma, is living out his dream of being an investment banker with a weeklong internship at Goldman Sachs.

The 48-year-old mum has not only continued caring for patients, but has taken up a martial art and started a Scout troop But her remarkable achievements despite being twice diagnosed with cancer have stunned the Bridgend community and landed her the Bridge FM Outstanding Adult Achievement Award.

Stater Bros. Charities and The Leukemia & Lymphoma Society concluded another successful "Light The Night" fundraising campaign in support of LLS' mission to find cures and ensure access to treatments for blood cancer patients.

MUTLEY has been a patient of ours for around a year and a half now and unfortunately, just over a year ago, she was diagnosed with lymphoma.

The firefighters shaved their heads to show solidarity for one of their own. The daughter of one of the firefighters was recently diagnosed with non-Hodgkins Lymphoma.

PORT CHESTER, N.Y. For the last eight years Port Chester's Lael Porcelli has run marathons, sprint triathlons and sold lemonade to support the Leukemia & Lymphoma Society and honor her niece, Katie Smercak, who was successfully treated for leukemia at the age of five.

A newly discovered particle may make changing hair color as easy as straightening it without chemicals, via ion beam technologies.

These are the moving stories of just a few of the the runners in the 2014 Great North Run , and we want to hear yours Why I'm running: My brother Adam Ball, 19, has Cystic Fibrosis and has to stick to a strict regime of medication and physiotherapy just to stay well.

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17 , which is associated with poor responses to standard treatment for CLL.

THREE firefighters from Bury were part of a team who blazed a trail across the country on their bikes to raise money for two worthy causes.

Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorisation for IMBRUVICA in the European Union.

Consultant haematologists Josh Wright, Nick Morley and Eddie Hampton, from the Royal Hallamshire Hospital, will be joined by two cancer patients, Harry Baines and Shane Bytheway, on the RideLondon to Surrey amateur race.

Approved use for Imbruvica has been expanded to include people with chronic lymphocytic leukemia who have a deletion in chromosome 17, the U.S. Food and Drug Administration said Monday in a news release.

Men and women with indolent, or low-grade, non-Hodgkin's lymphoma are needed for a clinical trial that evaluates medication of adults previously treated for the cancer.

Lymphoma treatment has damaging effects on spermatogenesis but, in most patients, sperm production recovers within two years post-treatment, according to a study published online July 17 in Fertility and Sterility .

MARTINSRIED / MUNICH, Germany, July 28, 2014 -- MorphoSys AG today provided an update on its proprietary portfolio including the clinical programs MOR208, MOR103 and MOR202.